MB

MPM BioImpact Portfolio holdings

AUM $577M
1-Year Est. Return 8.33%
This Quarter Est. Return
1 Year Est. Return
+8.33%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$622M
AUM Growth
+$195M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
44
New
Increased
Reduced
Closed

Top Buys

1
+$23.9M
2
+$23.1M
3
+$15.8M
4
RARE icon
Ultragenyx Pharmaceutical
RARE
+$11.5M
5
ETNB icon
89bio
ETNB
+$11.3M

Top Sells

1
+$16.9M
2
+$16.1M
3
+$14.4M
4
VKTX icon
Viking Therapeutics
VKTX
+$14.4M
5
GPCR icon
Structure Therapeutics
GPCR
+$9.4M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$130M 20.95%
7,648,268
2
$34.6M 5.56%
10,475,675
-239,945
3
$32.6M 5.24%
2,200,000
-1,089,470
4
$23.9M 3.84%
+1,516,183
5
$23.8M 3.83%
1,745,943
6
$23.1M 3.72%
+4,096,619
7
$22.5M 3.62%
480,588
+2,354
8
$22.1M 3.56%
1,953,690
+96,554
9
$16.4M 2.64%
61,399
+20,489
10
$15.8M 2.54%
+172,413
11
$15.5M 2.49%
2,388,011
12
$14.9M 2.39%
296,050
+1,474
13
$14.7M 2.37%
871,149
+206,163
14
$14.4M 2.32%
530,794
+2,644
15
$14.1M 2.27%
1,268,471
+3,712
16
$12.3M 1.98%
150,000
-175,284
17
$11.9M 1.91%
432,598
+50,000
18
$11.6M 1.86%
549,078
19
$11.5M 1.84%
+245,590
20
$11.5M 1.84%
325,333
+1,591
21
$11.3M 1.81%
+967,742
22
$10.8M 1.73%
614,010
+514,010
23
$10.7M 1.73%
+1,137,108
24
$9.21M 1.48%
4,166,496
+319,264
25
$9.11M 1.46%
114,127
+20,740
1
2